Amir Asnaashari
Mashhad University of Medical Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Amir Asnaashari.
Human & Experimental Toxicology | 2009
Davood Attaran; Shahrzad M. Lari; Mohammad Khajehdaluee; Hossein Ayatollahi; Mohammad Towhidi; Amir Asnaashari; Hassan Ghobadi Marallu; Maryam Mazloomi; Mahdi Balali Mood
Background: Sulfur mustard (SM) is a chemical warfare agent that can cause serious pulmonary complications. This study was designed to determine serum highly sensitive C-reactive protein (hs-CRP) and evaluate its correlation with lung function parameters in patients with chronic obstructive pulmonary disease (COPD) due to SM poisoning. Methods: Fifty consecutive SM patients with stable COPD and a mean age 46.3 ± 9.18 years were enrolled in this cross sectional study. Thirty healthy men were selected as controls. Lung function parameters were evaluated. Serum hs-CRP by immunoturbidometry assay was measured in both the patients and controls. Results: In the case group, the mean forced expiratory volume in one second (FEV1) was 2.14 ± 0.76 L (58.98% ± 17.51% predicted). The mean serum hs-CRP was 9.4 ± 6.78 SD and 3.9 ± 1.92 SD mg/L in the cases and controls, respectively, with significant statistical differences (p < .001). There was negative correlation between the serum hs-CRP and FEV1 levels (p = .01). The serum hs-CRP levels were also correlated with Global Initiative for Chronic Obstructive Lung disease (GOLD) stages (r = .45, p < .001). Conclusions: Our findings suggest that the serum hs-CRP level is increased in SM patients with COPD and may have a direct correlation with disease severity. It may then be used as a marker for the severity of COPD in patients with SM poisoning.
Asian Cardiovascular and Thoracic Annals | 2013
Reza Bagheri; Alireza Tavassoli; Seyed Ziaollah Haghi; Davoud Attaran; Ali Sadrizadeh; Amir Asnaashari; Reza Basiri; Maryam Salehi; Kamran Adhami Moghadam; Azadeh Tabari; Shima Sheibani
Aim To evaluate the efficacy of early video-assisted thoracoscopic debridement in patients with the fibropurulent phase of parapneumonic empyema. Patients and methods 40 patients with parapneumonic empyema resistant to 2 weeks of antibiotic therapy, were randomly divided into 2 groups. In group 1 (20 patients), antibiotic therapy and irrigation was continued, and in group 2 (20 patients), video-assisted thoracoscopic debridement was performed. The 2 groups were compared in terms of therapeutic results. Results The male/female ratio was 29/11. Group 1 included 16 men and 4 women with a mean age of 54 years, and mean hospital stay was 41 days. Group 2 consisted of 14 men and 6 women with a mean age of 51 years, and mean hospital stay was 23 days. Considering the therapeutic results, 12 patients in group 1 were cured by antibiotic therapy and irrigation, whereas 8 required decortication and pleurectomy with thoracotomy. In group 2, 18 patients were cured by video-assisted thoracoscopic debridement, and 2 underwent thoracotomy and decortication due to intraoperative bleeding. A significant difference in therapeutic results was noted between the groups (p = 0.028). Conclusion Video-assisted thoracoscopic debridement provides a high success rate and less invasive treatment for the early stages of empyema.
Interactive Cardiovascular and Thoracic Surgery | 2012
Reza Bagheri; Mohammad Taghi Rajabi-Mashhadi; Kiyarash Ghazvini; Amir Asnaashari; Ali Zahediyan; Mehdi Abasi Sahebi
Respiratory complication is one of the important postoperative complications of oesophageal cancer. The aim of this study was to evaluate whether neoadjuvant chemotherapy before surgery is effective for postoperative respiratory complications. In this study, patients with oesophageal cancer were divided into two group: one with neoadjuvant therapy and the other without neoadjuvant therapy. Before surgery, they all underwent bronchoscopy and bronchoalveolar lavage. We evaluated respiratory complications and the effects of preoperative neoadjuvant therapy. Forty patients (M/F = 23/17 and mean age 61 years) were enrolled in this study. Twenty-two cases had cancer in the middle part and 18 in the lower part of the oesophagus. Significant correlation was observed between the number of positive micro-organism and difficulty in weaning and receiving neoadjuvant therapy. But no significant correlation was found between neoadjuvant therapy and respiratory complications.
Jundishapur Journal of Microbiology | 2015
Roghayeh Ghazalsofala; Seyed Abdolrahim Rezaee; Houshang Rafatpanah; Rosita Vakili; Kiarash Ghazvini; Fatemeh Heidarnejad; Somaye Sobhani; Narges Valizadeh; Marayam Azami; Marzieh Rahimzadegan; Amir Asnaashari
Background: Tuberculosis (TB) is the worlds second most common infectious disease after Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome (HIV/AID) and the most frequent cause of mortality especially in developing countries. T regulatory (Treg) cells, which have suppressive activity and express forkhead winged-helix family transcriptional repressor p3 (FoxP3), suppress the immune responses against pathogens such as Mycobacterium tuberculosis. There are controversial results regarding the role of FoxP3 expressing cells in the blood of patients with TB. Objectives: The aim of this study was to evaluate the frequency CD4+ CD25+ Treg cells, and FoxP3 and Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) gene expressions in peripheral blood of patients with tuberculosis and patients with positive tuberculin skin test before and after Peripheral Blood Mononuclear Cells (PBMCs) activation with Purified Protein Derivative (PPD). Patients and Methods: In this cross-sectional study, Peripheral Mononuclear Cells (PBMCs) were isolated from peripheral blood of 29 patients with newly diagnosed pulmonary TB and 19 patients with positive tuberculin skin test. The PBMCs were activated with PPD for 72 hours. Activated cells were harvested, RNA was extracted and cDNA was synthesized. A real-time Taqman method was designed and optimized for evaluation of Foxp3 gene expression and SYBR Green method was used and optimized for evaluation of CTLA-4 gene expression. A flow cytometry analysis was used to evaluate the frequency of CD4+ CD25+ Foxp3+ regulatory T cells in both groups. Results: There was no significant difference in the frequency of CD4+ CD25+ FoxP3+ regulatory T cells between the two groups. Expression of FoxP3 and CTLA-4 in peripheral blood of patients with newly diagnosed TB was significantly lower than the control group after and before activation with PPD. Conclusions: The expression of FoxP3 and CTLA-4 in PBMCs of patients with newly diagnosed TB was low, which might suggest that Treg cells may be sequestered in the lungs.
Otolaryngology-Head and Neck Surgery | 2011
Amir Asnaashari; Atefeh Amiri Darban; Mahasti Babaeian; Mohammad Taiarani; Saman Rezaei; seideh sedigheh fatemi; Mohammad Taghi Shakeri
Objective: The effect of upper respiratory tract diseases on phonation has been reviewed, but the effect of lower respiratory tract diseases on phonation has been little studied. The influence of asthma as a reversible obstructive small airway disease on phonatory variables is not clear yet. Method: This cross sectional, case control trial was performed from March to September 2008 to evaluate the quality of phonation in asthma. Eight vocal parameters were evaluated in 34 asthmatic patients and a control group by a voice meter device using Dr Speech statistical software. Results: Vocal variables such as FO, Jitter, and Shimmer were almost similar in both groups statistically. This fact likely reflects the normal phonatory mechanism at the level of vocal cords in asthmatic patients, but harshness, hoarseness, NNE, S/Z ratio (P < .01) and breathy voice (P = .015) were different statistically. This indicates the role of the lower airway in the phonation process. Conclusion: Small airway diseases such as asthma may have direct effect on phonation, but we suggest further studies with more cases.
Iranian Journal of Allergy Asthma and Immunology | 2012
Amir Asnaashari; Ali Talaei; Mehry Baghban Haghighi
Tanaffos: Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis | 2011
Amir Asnaashari; Mohammad Towhidi; Reza Farid; Mohammad Reza Abbaszadegan; Davood Attaran; Seiedeh Sedigheh Fatemi; Atefeh Amiri Darban
Iranian Journal of Basic Medical Sciences | 2016
Fatemeh Heidarnezhad; Amir Asnaashari; Seyed Abdolrahim Rezaee; Roghayeh Ghezelsofla; Kiarash Ghazvini; Narges Valizadeh; Reza Basiri; Aghigh Ziaeemehr; Somayeh Sobhani; Houshang Rafatpanah
Ear, nose, & throat journal | 2012
Amir Asnaashari; Saman Rezaei; Mahasti Babaeian; Taiarani M; Mohammad Taghi Shakeri; seideh sedigheh fatemi; Atefeh Amiri Darban
Tanaffos: Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis | 2013
Majid Mirsadraee; Amir Asnaashari; Davood Attaran; Saeed Naghibi; Saeed Mirsadraee